InvestorsHub Logo
Followers 3
Posts 38
Boards Moderated 0
Alias Born 08/14/2020

Re: JulieA post# 32807

Tuesday, 12/22/2020 3:40:52 PM

Tuesday, December 22, 2020 3:40:52 PM

Post# of 44690
Julie, below is my understanding. Just information not investing advice. Please see link to BRPA 8k filing below and do your own DD before investing. I’m no expert and SPAC are high risk investments.

BRPA will become 1 common share of NeuroRX after merger with BRPA completed. If merger falls through you will get $10 per share from trust and lose the rest.

BRPAW are warrants. Each warrants gives you the right to buy 1 shares of common stock in post-merger company for 11.50. There are additional limitations as to cooling period after merger before you can exercise, and company can force to exercise if stock runs too high for too long. These become worthless if merger falls through.

BRPAR is right to 1/10 of a common share of post merger company. Automatically converted post merger but worthless if falls through.

BRPAU is 1 common stock, 1 rights, and 1/2 a warrant.

IMO BRPAR is where it’s at right now given price point of BRPA and BRPAW, but I wouldn’t hold on to any of them for too long if they really run.

https://www.sec.gov/Archives/edgar/data/1719406/000165495420013700/brpa_8k.htm